In the News

Russo Partners works at the intersection of science, medicine, and media. The stories below reflect the conversations we help shape covering breakthroughs in biopharma, digital health, healthcare, and beyond.

Clarivate

August 5, 2026

7 weight loss companies to watch: innovators in GLP-1s and beyond

The market for weight loss treatments is a crowded one, and new entrants are piling in. The latest in our…

For more

Pulse 2.0

August 5, 2026

Ratio Therapeutics Raises $70 Million Series C To Advance Radiopharmaceutical Pipeline

Ratio Therapeutics has raised $70 million in Series C funding to advance its targeted radiopharmaceutical pipeline and expand its manufacturing…

For more

San Diego Union Tribune

July 28, 2026

His father suffered from gout in silence. Now a San Diego scientist is bringing the cure home

As a child, James Mackay watched his father struggle just to stand up. “You shouldn’t have eaten this or that,”…

For more

The Wall Street Journal

July 23, 2026

Biotech Startup Gets $130 Million to Settle ‘Unfinished Business’

James Mackay’s previous effort to provide gout patients with a novel treatment ended in disappointment. Venture capitalists are helping him…

For more

Biopharma Dive

July 22, 2026

Crystalys nets $130M more to push gout drug through late-stage tests

Less than a year after landing a big funding round, Crystalys Therapeutics has banked a second one, announcing Wednesday a…

For more

Scrip Citeline

July 16, 2026

BIO 2026: Catching Up With Vaxart, Aphaia, Connect Biopharma, Kyverna And Chugai

The recent BIO International Convention offered an opportunity to check in with biopharmaceutical companies about near-term milestones and long-term strategies. Scrip spoke…

For more